More about

Positron Emission Tomography Computed Tomography

News
August 07, 2024
3 min watch
Save

VIDEO: Phosphorylated tau assays most accurate in identifying amyloid PET status

PHILADELPHIA — In this Healio Video Perspective, Suzanne E. Schindler, MD, PhD, revealed phosphorylated tau biomarker assays were most accurate in identifying amyloid positron emission tomography status in Alzheimer’s disease.

News
August 18, 2023
1 min read
Save

Blood test boosts diagnostic accuracy for Alzheimer’s by calculating amyloid probability

C2N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and cerebrospinal fluid tests to assist in accurate diagnosis for those presenting with signs or symptoms of Alzheimer’s disease.

News
December 15, 2021
2 min read
Save

New tool may improve risk stratification of men with high-risk prostate cancer

A proxy for prostate-specific membrane antigen PET/CT upstaging was strongly predictive of meaningful, long-term cancer-specific outcomes, according to results of a multinational cohort study published in JAMA Network Open.

News
December 01, 2020
2 min read
Save

FDA approves PET imaging drug for prostate cancer

The FDA today approved Gallium 68 PSMA-11 as the first drug for PET imaging of prostate-specific membrane antigen-positive lesions in men with prostate cancer, according a press release from the agency.

News
October 28, 2020
2 min read
Save

PET molecular imaging helps guide treatment, improves DFS in recurrent prostate cancer

The addition of PET molecular imaging to conventional imaging helped guide treatment decisions that led to improved DFS among men with recurrent prostate cancer, according to study results presented at the virtual ASTRO Annual Meeting.

News
May 06, 2020
3 min read
Save

Racial disparities observed in guideline-recommended lung cancer imaging

Blacks and Hispanics appeared less likely than non-Hispanic whites to receive guideline-recommended PET/CT imaging at the time of lung cancer diagnosis, according to results of a study published in Journal of the National Cancer Institute.

News
March 23, 2020
3 min read
Save

Novel technique outperforms traditional imaging for high-risk prostate cancer

A novel molecular imaging technique demonstrated higher diagnostic accuracy than conventional imaging among a cohort of men with high-risk prostate cancer, according to results of a randomized phase 3 study published in The Lancet.

News
February 24, 2020
3 min read
Save

De-escalation chemotherapy after negative PET scan appears safe in low-volume metastatic seminoma

De-escalation of treatment after two cycles of chemotherapy and a negative PET scan appeared safe and feasible among a cohort of men with low-volume metastatic seminoma, according to results of a phase 2 trial presented at Genitourinary Cancers Symposium.

News
September 16, 2019
4 min read
Save

A 75-year-old woman with constitutional symptoms, precipitous functional decline

A 75-year-old woman with a medical history significant for obesity, diabetes mellitus type 2 and coronary artery disease presented with a 6-month history of constitutional symptoms, multiple hospitalizations for dehydration and electrolyte imbalances, and a precipitous functional decline. She was noted on several occasions to have a marked leukocytosis and was treated with various antibiotic regimens without a known infectious source. A CT scan of the chest/abdomen/pelvis revealed what was thought to be an enlarged inguinal lymph node (Figure 1).